Drugs in the Pipeline April 2022: Drug Pipeline Updates By Brian Park, PharmD Publish Date May 9, 2022
News Rinvoq Approved for Active Ankylosing Spondylitis By Brian Park, PharmD Publish Date May 2, 2022
News Ultomiris Approved for Generalized Myasthenia Gravis By Brian Park, PharmD Publish Date April 28, 2022
Safety Alerts and Recalls Hidden Drugs Found in Supplements Promoted for Musculoskeletal Conditions By Diana Ernst, RPh Publish Date April 21, 2022
Drugs in the Pipeline Pentosan Polysulfate Sodium SC Injection Fast Tracked for Osteoarthritis By Brian Park, PharmD Publish Date April 13, 2022
Drugs in the Pipeline Efzofitimod Granted Orphan Drug Status for Systemic Sclerosis By Brian Park, PharmD Publish Date April 13, 2022
News Intra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis Publish Date April 11, 2022
Safety Alerts and Recalls Nitrosamine Impurity Detected in Certain Lots of Orphenadrine Citrate ER Tablets By Brian Park, PharmD Publish Date March 24, 2022
News Risk for Shoulder Conditions Small After Vaccination in Deltoid Muscle Publish Date March 22, 2022
Drugs in the Pipeline Pegloticase Plus Methotrexate Gets Priority Review for Uncontrolled Gout By Brian Park, PharmD Publish Date March 7, 2022